Anagrelide Trichloro Derivative

Development and Validation of a Stability-Indicating RP-HPLC Method for the Quantitative Analysis of Anagrelide Hydrochloride
Sudhakar S. Pujeri,Addagadde M. A. Khader, andJaldappagari Seetharamappa
Sci. Pharm. 2012, 80(3), 567-580
 
Method Development and Validation for Estimation of Anagrelide Hydrochloride Capsules by RP-HPLC in Bulk and Dosage Forms
M Sudhakar *, P Lavanya, P Deepika and SK Abdul Rahman
Indo American Journal of Pharmacy An International Peer Review Journal © PHS Scientific HouseVolume 1 (1), 2015, Page-22-27

Anagrelide Trichloro Derivative is chemically 6,7,8-Trichloro-3,5-dihydroimidazo[2,1-b]quinazolin-2(1H)-one (as per USP). It is also known as 8-Chloro Anagrelide . Anagrelide Trichloro Derivative is supplied with detailed characterization data compliant with regulatory guideline. Anagrelide Trichloro Derivative can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Anagrelide.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.